N4 Pharma Plc (LON:N4P – Get Free Report)’s share price passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 0.53 ($0.01) and traded as low as GBX 0.50 ($0.01). N4 Pharma shares last traded at GBX 0.58 ($0.01), with a volume of 3,777,685 shares.
N4 Pharma Stock Performance
The stock has a 50 day simple moving average of GBX 0.53 and a 200 day simple moving average of GBX 0.62. The stock has a market cap of £2.37 million, a P/E ratio of -59.00 and a beta of -0.37. The company has a current ratio of 14.86, a quick ratio of 7.28 and a debt-to-equity ratio of 1.62.
About N4 Pharma
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
See Also
- Five stocks we like better than N4 Pharma
- How to Calculate Inflation Rate
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- How to Calculate Stock Profit
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
